Journal of Clinical and Diagnostic Research (Sep 2020)

Epitheloid Angiosarcoma of Liver: A Hanging Tumour

  • Aniruddha Bhosale,
  • Priyanka Ghodekar,
  • Wipula Deshmukh,
  • Shailesh Sable,
  • Bipin Vibhute

DOI
https://doi.org/10.7860/JCDR/2020/44614.13996
Journal volume & issue
Vol. 14, no. 9
pp. PD08 – PD11

Abstract

Read online

Primary Epitheloid Angiosarcoma (EA) of liver is an aggressive malignant tumour with poor prognosis irrespective of aggressive surgical resection with or without adjuvant therapy. It constitutes for 0.1-2% of primary malignant tumours of liver and is seen commonly in sixth or seventh decade of life, with male preponderance. It can be asymptomatic or may present with nonspecific symptoms. Lack of pathognomonic features on serological, biochemical and radiological tests, makes it even difficult for an early diagnosis. Despite early surgical removal, EA has very high recurrence rate. Chemotherapy agents (paclitaxel, bevacizumab) and immunomodulators (mTOR inhibitors) have shown some survival benefit and reduction in recurrence rates in recent years as adjuvant therapy. To the best of our knowledge, a hanging morphological variant of EA of liver has not been reported yet in literature. Author here by report a case of 37-years-old male incidentally diagnosed with aggressive, hanging variant of EA of liver. Despite early surgical resection and adjuvant, after chemotherapy patient had survival of less than eight months since first presentation.

Keywords